Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

Clinical trial NCT01109121 · COMPLETED

Trial details

NCT number: NCT01109121
Sponsor: Nuon Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate to Severe Gout Hyperuricemia

Start date: 2010-06-01
Primary completion: 2010-12-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.